Stock Screener · Library
DAMORA THERAPEUTICS, INC. financial statement history
Source-linked financial facts for DAMORA THERAPEUTICS, INC. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 122215000 | USD | 2023-03-09 | 2022 / FY | us-gaap:Assets | 10-K · 0000950170-23-006807 |
| As of 2022-12-31 | 73188000 | USD | 2024-03-08 | 2023 / FY | us-gaap:Assets | 10-K · 0000950170-24-028610 |
| As of 2023-12-31 | 38227000 | USD | 2025-03-19 | 2024 / FY | us-gaap:Assets | 10-K · 0000950170-25-041981 |
| As of 2024-12-31 | 17132000 | USD | 2026-03-19 | 2025 / FY | us-gaap:Assets | 10-K · 0001193125-26-115922 |
| As of 2025-12-31 | 260527000 | USD | 2026-03-19 | 2025 / FY | us-gaap:Assets | 10-K · 0001193125-26-115922 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 110102000 | USD | 2023-03-09 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-23-006807 |
| As of 2022-12-31 | 63910000 | USD | 2024-03-08 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-24-028610 |
| As of 2023-12-31 | 36774000 | USD | 2025-03-19 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0000950170-25-041981 |
| As of 2024-12-31 | 16839000 | USD | 2026-03-19 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001193125-26-115922 |
| As of 2025-12-31 | 260423000 | USD | 2026-03-19 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001193125-26-115922 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 62563000 | USD | 2023-03-09 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-23-006807 |
| As of 2022-12-31 | 32786000 | USD | 2024-03-08 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-24-028610 |
| As of 2023-12-31 | 21465000 | USD | 2025-03-19 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0000950170-25-041981 |
| As of 2024-12-31 | 14175000 | USD | 2026-03-19 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-115922 |
| As of 2025-12-31 | 257624000 | USD | 2026-03-19 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001193125-26-115922 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 203000 | USD | 2023-03-09 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-23-006807 |
| As of 2022-12-31 | 357000 | USD | 2024-03-08 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-24-028610 |
| As of 2023-12-31 | 78000 | USD | 2025-03-19 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0000950170-25-041981 |
| As of 2024-12-31 | 57000 | USD | 2026-03-19 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001193125-26-115922 |
| As of 2025-12-31 | 36000 | USD | 2026-03-19 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001193125-26-115922 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 4992000 | USD | 2023-03-09 | 2022 / FY | us-gaap:Liabilities | 10-K · 0000950170-23-006807 |
| As of 2022-12-31 | 11435000 | USD | 2024-03-08 | 2023 / FY | us-gaap:Liabilities | 10-K · 0000950170-24-028610 |
| As of 2023-12-31 | 5896000 | USD | 2025-03-19 | 2024 / FY | us-gaap:Liabilities | 10-K · 0000950170-25-041981 |
| As of 2024-12-31 | 1301000 | USD | 2026-03-19 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001193125-26-115922 |
| As of 2025-12-31 | 20147000 | USD | 2026-03-19 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001193125-26-115922 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 4544000 | USD | 2023-03-09 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-23-006807 |
| As of 2022-12-31 | 11107000 | USD | 2024-03-08 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-24-028610 |
| As of 2023-12-31 | 5830000 | USD | 2025-03-19 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0000950170-25-041981 |
| As of 2024-12-31 | 1197000 | USD | 2026-03-19 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001193125-26-115922 |
| As of 2025-12-31 | 20066000 | USD | 2026-03-19 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001193125-26-115922 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 117223000 | USD | 2024-03-08 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-24-028610 |
| As of 2022-12-31 | 61753000 | USD | 2025-03-19 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0000950170-25-041981 |
| As of 2023-12-31 | 32331000 | USD | 2026-03-19 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-115922 |
| As of 2024-12-31 | 15831000 | USD | 2026-03-19 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-115922 |
| As of 2025-12-31 | 240380000 | USD | 2026-03-19 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001193125-26-115922 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 38488000 | USD | 2023-03-09 | 2022 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-23-006807 |
| 2022-01-01 to 2022-12-31 | 48206000 | USD | 2024-03-08 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-24-028610 |
| 2023-01-01 to 2023-12-31 | 23770000 | USD | 2025-03-19 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0000950170-25-041981 |
| 2024-01-01 to 2024-12-31 | 6398000 | USD | 2026-03-19 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001193125-26-115922 |
| 2025-01-01 to 2025-12-31 | 26877000 | USD | 2026-03-19 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001193125-26-115922 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -52227000 | USD | 2023-03-09 | 2022 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-23-006807 |
| 2022-01-01 to 2022-12-31 | -61207000 | USD | 2024-03-08 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-24-028610 |
| 2023-01-01 to 2023-12-31 | -39905000 | USD | 2025-03-19 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0000950170-25-041981 |
| 2024-01-01 to 2024-12-31 | -22260000 | USD | 2026-03-19 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001193125-26-115922 |
| 2025-01-01 to 2025-12-31 | -210872000 | USD | 2026-03-19 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001193125-26-115922 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -51752000 | USD | 2023-03-09 | 2022 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-23-006807 |
| 2022-01-01 to 2022-12-31 | -61624000 | USD | 2024-03-08 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-24-028610 |
| 2023-01-01 to 2023-12-31 | -38349000 | USD | 2025-03-19 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0000950170-25-041981 |
| 2024-01-01 to 2024-12-31 | -21439000 | USD | 2026-03-19 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001193125-26-115922 |
| 2025-01-01 to 2025-12-31 | -209839000 | USD | 2026-03-19 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001193125-26-115922 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -2.05 | USD/shares | 2023-03-09 | 2022 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-23-006807 |
| 2022-01-01 to 2022-12-31 | -2.43 | USD/shares | 2024-03-08 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-24-028610 |
| 2023-01-01 to 2023-12-31 | -36.08 | USD/shares | 2025-03-19 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0000950170-25-041981 |
| 2024-01-01 to 2024-12-31 | -18.53 | USD/shares | 2026-03-19 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001193125-26-115922 |
| 2025-01-01 to 2025-12-31 | 3.98 | USD/shares | 2026-03-19 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001193125-26-115922 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -52308000 | USD | 2023-03-09 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-23-006807 |
| 2022-01-01 to 2022-12-31 | -42932000 | USD | 2024-03-08 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-24-028610 |
| 2023-01-01 to 2023-12-31 | -36911000 | USD | 2025-03-19 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0000950170-25-041981 |
| 2024-01-01 to 2024-12-31 | -18623000 | USD | 2026-03-19 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001193125-26-115922 |
| 2025-01-01 to 2025-12-31 | -6726000 | USD | 2026-03-19 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001193125-26-115922 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 223000 | USD | 2023-03-09 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-23-006807 |
| 2022-01-01 to 2022-12-31 | 196000 | USD | 2024-03-08 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0000950170-24-028610 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1800315
- Ticker in native snapshot
- DMRA
- Reported numeric facts
- 62
- Units present
- USD · USD/shares